OpenVSafe by OpenVAERS
Search V-safe

BLR-17620-33950

2 vaccinations 4 coded responses 15 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
920 / CA
Registered
2021-05-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-05-21
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-22
    Registered in v-safe
  3. 2021-05-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-05-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-05-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-05-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-05-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-05-28
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-06-04
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-06-21
    Dose 2 — Pfizer-BioNTech
  11. 2021-06-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good · Site: Pain
    Free text:
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-06-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-06-28
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-07-07
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-07-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-07-19
    Survey response — day 28, dose 2
    MedDRA: Acne, Heavy menstrual bleeding, Menopause — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Ive been in a premenopausal stage for 6 mos, 2-3 periods during that time which were lighter & shorter than my normal. 2 weeks after the 2nd vaccine, I experienced a very heavy period lasting much longer than my normal. Also, minor acne on my face
    MedDRA releases: 2024-11 · check-in free text available
  17. 2021-09-21
    Survey response — 3 months, dose 2
    MedDRA: Heavy menstrual bleeding — Feeling: Good · Be unable to do your normal daily activities
    Free text: Heavier and longer than normal menstrual periods (3 of them, every 4 weeks, since 2nd vaccination).Before vaccination, I was perimenopausal. No underlying medical issues that have caused the change in my menstrual cycle
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-06-21
    Survey response — 12 months, dose 2
    MedDRA: Body temperature increased, Fatigue, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Experienced extreme fatigue and low grade temperature. Took at-home Covid-19 test with a positive result
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-05-21Pfizer-BioNTech
22021-06-21Pfizer-BioNTech No

Free text

Release 9 — days 1–6 daily, dose 2

2021-06-25

Release 9 — day 28, dose 2

2021-07-19

Symptoms: Ive been in a premenopausal stage for 6 mos, 2-3 periods during that time which were lighter & shorter than my normal. 2 weeks after the 2nd vaccine, I experienced a very heavy period lasting much longer than my normal. Also, minor acne on my face

Release 9 — 3 months, dose 2

2021-09-21

Symptoms: Heavier and longer than normal menstrual periods (3 of them, every 4 weeks, since 2nd vaccination).Before vaccination, I was perimenopausal. No underlying medical issues that have caused the change in my menstrual cycle

Release 12 — 12 months, dose 2

2022-06-21

Symptoms: Experienced extreme fatigue and low grade temperature. Took at-home Covid-19 test with a positive result

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAcne · · ✓
SDBody temperature increased · · ✓
SDFatigue · · ✓
SDHeavy menstrual bleeding · · ✓
SDMenopause · · ✓
SDSARS-CoV-2 test positive · · ✓
SRONo adverse event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release